The therapeutic effects of different given ways of sandostatin in patients with acute edematous pancreatitis

QIN Guo-tao,GAO Pu-jun
DOI: https://doi.org/10.3969/j.issn.1674-8182.2006.02.005
2006-01-01
Abstract:Objective To assess the difference between the two ways of subcutaneous injection and intravenous drip,in which Sandostatin is given to treat acute edematous pancreatitis(AEP).Methods 112 patients with AEP were divided into four groups according to age and the way that Sandostatin was given.Abdominal pain duration,vomiting and nausea duration,fever duration,the incidence of complications and surgry,mortaligy,occurrence rate of severe aute pancreatitis(SAP) were investigated and compared.Results In patients with AEP whose age>55,abdominal pain duration was(2.6±1.5)days in sandostatin intravenous drip group and(4.7±1.5)days in subcutaneous group respectively(P<0.05);the postive rate of amylase in serum on the fifth day after treatment was 28.6% in intravenous group and 56.7% in subcutaneous group(P<0.05);in pantients with AEP whose age≤55,the postive rate of amylase in blood on the third day after treatment were 11.1% and 35.3% in intravenous and subcutaneous group respectively(P<0.05).Conclusions It is more effective that sandostatin was given to patients with AEP by intravenous drip than by subcutaneous injecton.The way of intraveneus drip can shorten the course of the disease and improve prognosis.
What problem does this paper attempt to address?